Thursday, January 30, 2020

January 30, 2020 at 08:16PM NucliSens HIV-1 QT

In conjunction with clinical presentation and other laboratory markers of disease progression for prognostic assessment of HIV-1 infected patients, and for monitoring the effects of anti-retroviral therapy by serial measurements of plasma HIV-1 RNA for pediatric and adult patients with baseline vir

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38QvjFb

No comments:

Post a Comment